SCHEMBL6177954

SCHEMBL6177954

Cc1ccc2c(c1)N(CC(=O)c1ccccc1C)C(=O)C(NC(=O)OC(C)(C)C)CN2C(=O)c1cccs1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.38
LMNA P02545 3/20 0.38
TSHR P16473 2/20 0.37
ALDH1A1 P00352 2/20 0.37
CTNNB1 P35222 1/20 0.36
WNT3A P56704 1/20 0.36
CCKBR P32239 3/20 0.36
MAPT P10636 2/20 0.35
CYP3A4 P08684 1/20 0.35
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPK1 P28482 1/20 0.34
SCN9A Q15858 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7960425 0.92 ALDH1A1 (0.40) TP53LMNATSHRALDH1A1CCKBR
SCHEMBL6177504 0.88 CCKBR (0.39) TSHRCCKBRMAPTCYP3A4
SCHEMBL6177392 0.88 CCKBR (0.39) LMNATSHRCCKBRMAPTCYP3A4
SCHEMBL6176603 0.87 CCKBR (0.39) LMNATSHRCCKBRMAPTCYP3A4
SCHEMBL6176679 0.87 CCKBR (0.46) TSHRCCKBRMAPTCYP3A4
SCHEMBL7962064 0.85 CCKBR (0.36) TP53LMNATSHRALDH1A1CCKBR
SCHEMBL7959399 0.85 CCKBR (0.38) LMNATSHRCCKBRMAPTCYP3A4
SCHEMBL7961059 0.85 XIAP (0.39) TSHRCTNNB1WNT3ACCKBRMAPT
SCHEMBL7959563 0.85 HTT (0.37) TP53LMNATSHRALDH1A1CCKBR
SCHEMBL6178660 0.85 CCKBR (0.38) LMNATSHRCCKBRMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0945445-B9 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2005-12-28 EP disclosed
EP-0945445-B1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-09-03 EP disclosed
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed
EP-0945445-A1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-09-29 EP disclosed